C
Abeona Therapeutics Inc. ABEO
$6.91 -$0.04-0.58% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -34.44% 37.94% 9.74% 31.44% -8.71%
Gross Profit 38.78% -37.94% -9.74% -31.44% -39.71%
SG&A Expenses 98.35% 37.39% 31.70% 54.09% 72.20%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 29.83% 37.66% 26.22% 35.39% 18.16%
Operating Income -27.59% -37.66% -26.22% -35.39% -53.75%
Income Before Tax 1,578.98% 61.91% 43.99% -155.74% 144.47%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 1,369.52% 61.91% 43.99% -155.74% 144.47%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 1,369.52% 61.91% 43.99% -155.74% 144.47%
EBIT -27.59% -37.66% -26.22% -35.39% -53.75%
EBITDA -28.03% -38.69% -26.85% -37.41% -57.92%
EPS Basic 1,019.39% 79.10% 70.44% -31.89% 120.03%
Normalized Basic EPS -388.16% 79.10% 70.35% -31.91% 118.83%
EPS Diluted 749.79% 79.10% 70.44% -31.89% 71.60%
Normalized Diluted EPS -390.71% 79.10% 70.35% -31.91% 114.71%
Average Basic Shares Outstanding 31.28% 82.24% 89.46% 93.90% 122.06%
Average Diluted Shares Outstanding 30.09% 82.24% 89.46% 93.90% 184.31%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --